Hepatitis D - 32 Studies Found
| Recruiting |
: Ezetimibe for Patients With Chronic Hepatitis D : Chronic Hepatitis D : 2017-03-28 : Drug: Ezetimibe Ezetimibe 20 mg oral daily |
| Completed |
: Lonafarnib for Chronic Hepatitis D : Hepatitis D : 2011-12-16 :
|
| Recruiting |
: The Hepatitis Delta International Network : Hepatitis D : 2015-02-19 |
| Completed |
: Pegylated Interferon to Treat Chronic Hepatitis D : Hepatitis D : 2001-09-03 : Drug: Peginterferon Alpha-2a Treatment |
| Active, not recruiting |
: Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D : Hepatitis D, Chronic : 2017-03-26 :
|
| Terminated |
: Proof-of-concept Study Evaluating the Safety and Efficacy of EBP921 in Delta Hepatitis (HDV) : Hepatitis D : 2011-03-14 : Drug: EBP921 Patients randomized to receive low or high dose. All dosing of EBP921 should be taken with |
| Completed |
: Treatment of Chronic Delta Hepatitis With Lonafarnib and Ritonavir : Hepatitis D : 2015-07-29 :
|
| Completed |
: A Study of Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD) : Hepatitis D, Chronic : 2016-04-05 : Drug: Pegylated Interferon (PEG-IFN) alfa-2a Participants received pegylated interferon (PEG-IFN) alfa-2 |
| Completed |
: A Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD) : Hepatitis D, Chronic : 2016-04-01 :
|
| Terminated |
: An Observational Study on the Prevalence of Chronic Hepatitis D in Romania and the Efficacy of Treatment With Pegasys (Peginterferon Alfa-2a) : Hepatitis D, Chronic : 2013-05-02 |